
Tel: 301.424.9700 · Fax: 301.296.4751 · Email: info@grs-cro.com · Other locations


GRS does not provide everything to everybody; rather, we provide the very best in service to those companies who share our philosophy and our goal to partner in bringing new drugs, biologics, and devices to market.
Global Research Services (GRS) is an international Contract Research Organization (CRO) providing comprehensive services for clinical trials management to the pharmaceutical, biotechnology and medical device industries.
In March 2007, GRS was created through the purchase of the assets of the Clinical Research Services division of Medifacts International. Continuing to maintain the same corporate infrastructures across all locations, GRS was able, in a seamless fashion, to continue providing excellence in service to our valued clients and investigators worldwide.
Now as an independent corporation, GRS retains the most valuable assets of this division—its experienced personnel, its extensive expertise, and its established processes and procedures in clinical research operations. We offer performance, reliability, demonstrated therapeutic experience, innovative business solutions, and a full range of services. These services include: project management, monitoring, comprehensive data management, biostatistics, medical writing and pharmacovigilance. GRS is headquartered in Rockville, Maryland and has incorporated subsidiary offices in Montreal, Canada, Langenfeld, Germany, Warsaw, Poland and Shanghai, China.
The GRS staff, and therefore the company, has a rich history, experience, demonstrated competence, and innovation in the clinical research arena.
GRS has carved a unique position among the specialized CROs managing global clinical trials. We continue to raise the bar with our commitment to hiring and retaining the best “intellectual assets”. Our staff has demonstrated expertise in designing and implementing innovative, well-differentiated technologies that address the variables which affect the increasing failure rate for prospective drugs in clinical trials.